Navigation Links
Elekta Emphasizes Advantages of Leksell Gamma Knife Perfexion Over Competing Systems at 2011 AANS Meeting
Date:4/8/2011

ATLANTA and DENVER, April 8, 2011 /PRNewswire/ -- At the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, April 9-13 at the Colorado Convention Center, Elekta (booth #1717) will highlight characteristics of Leksell Gamma Knife® Perfexion™ that separate the system from other radiosurgery solutions. These include its dedication to intracranial cases, complete solution integration, industry-leading accuracy, "shrink-wrap" dose conformity and extensively proven clinical efficacy. Demonstrations of the system will emphasize that Perfexion is designed to minimize the risk of human error and radiation toxicity, while optimizing accuracy and dose conformance.

The ability of Leksell Gamma Knife® to limit radiation exposure to normal tissues was presented in an article published in a recent issue of the Journal of Neurosurgery(1). Investigators found that among three different treatment platforms, therapy planned with Leksell Gamma Knife would result in "much smaller normal brain volumes receiving any particular dose" than plans developed with the two other systems.

Extending the reach of Gamma Knife surgery

The opportunity to expand the clear clinical and safety advantages of Perfexion is realized in the Extend™ system, which also will be exhibited at the Elekta booth. Extend enables multi-session hypofractionation of a therapy that is traditionally a single-session treatment. Extend enables clinicians to treat – over two to five fractions – patients with larger tumors or lesions close to critical structures located in the brain, skull base and in other head/neck regions. Extend non-invasively immobilizes the patient's head, making hypofractionated therapy using Perfexion practical for these cases.

Other meeting highlights

At AANS, Elekta also will exhibit several other solutions that improve the management of neurological and neurosurgical cases, including:

  • Elekta Neuromag® TRIUX, the latest generation magnetoencephalography (MEG) system

  • Elekta Axesse™, an advanced, versatile stereotactic treatment system, designed to facilitate highly targeted stereotactic body radiation therapy (SBRT) and radiosurgery (SBRS) anywhere in the body

  • SonoWand Invite™, an intra-operative imaging system with high quality 3D ultrasound and navigation for brain surgery

  • Leksell Stereotactic System® for functional neurosurgery. Exceptional imaging, high platform rigidity and ease of use ensure that critical accuracy requirements are met for this surgical discipline

  • Leksell SurgiPlan®, Elekta's advanced image-based neurosurgical planning software specifically designed for Leksell Stereotactic System®

Leksell Radiosurgery Award winner to be announced

On April 11, the AANS will present the 2011 Leksell Radiosurgery Award to Dr. Robert Starke from the University of Virginia Health Sciences Center. As part of the program, Dr. Starke will give a talk, titled "Gamma Knife Radiosurgery of Meningiomas Located in the Posterior Fossa: Factors Predictive of Outcome and Recurrence."

(1.) Ma L, Petti P, Wang B, et al. Apparatus dependence of normal brain tissue dose in stereotactic radiosurgery for multiple metastases. Published online March 4, 2011; DOI: 10.3171/2011.1.JNS101056.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.

Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.

Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.

Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta-sponsored Ceremony Honors Arizona Cancer Heroes
2. Nottingham University Hospital is First U.K. User of Elektas Electronic Medical Record Workspace for Image Guided Radiation Therapy
3. Elektas Oncology-Specific MOSAIQ Receives Complete ONC-ATCB EMR Certification
4. Elektas MOSAIQ Oncology Information System Named Category Leader in 2010 Top 20 Best in KLAS Awards Report
5. Elekta Receives FDA 510(k) Clearance for XiO Software to Plan Spot Scanning for Proton Therapy
6. Elekta Introduces MOSAIQ Data Director, Image and Data Hub for Oncology
7. Elekta to Highlight Latest Gamma Knife Surgery Innovations at Annual Neurosurgery Conference
8. Healthcare Providers Rate Elektas MOSAIQ Oncology Information System as No. 1 in 2010 KLAS Report
9. Elekta Launches ABAS 2.0 Autosegmentation Software Used to Plan Radiation Therapy in Patients With Cancer
10. Elekta Among Major Sponsors of Rocks Against Cancer Fundraiser
11. Open House at Gulf Coast Cancer Treatment Center Introduces Elekta Synergy® to Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... 4, 2016 Wegener Polyangiitis - Pipeline ... Direct,s, ,Wegener Polyangiitis - Pipeline Review, H2 2015, ... pipeline. This report provides comprehensive information on ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ...
(Date:2/4/2016)... 2016 Frontier Pharma: Chronic Obstructive Pulmonary ... Chronic Obstructive Pulmonary Disease (COPD) ... of the airways and lungs. Persistent breathing difficulties ... disease one of the leading causes of morbidity ... world. COPD is linked to cumulative exposure to ...
(Date:2/4/2016)... -- In response to the opioid abuse epidemic, today Dr. ... Products and Tobacco, along with other FDA leaders, called for ... opioid medications. The plan will focus on policies aimed at ... to effective relief. --> ... risk-benefit paradigm for opioids and ensure that the agency considers ...
Breaking Medicine Technology:
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... the ability to correct pelvic organ prolapse with the latest techniques and the ... at greatest risk for pelvic organ prolapse, particularly after menopause. Other risk factors ...
(Date:2/7/2016)... ... 2016 , ... HealthSmart Holdings, Inc. announced today the launch ... and information to lower the costs, and increase the impact of their healthcare ... healthcare benefits by as much as 22%:, + Price and quality transparency, ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , ... with an estimated 5000 perioperative nurses in attendance to study the latest ...
(Date:2/6/2016)... , ... February 06, 2016 , ... With the ... add warm color grades to their footage. A LUT is a Lookup Table that ... to the corresponding color indicated by the table. By manipulating each pixel, LUT's can ...
(Date:2/6/2016)... ... 06, 2016 , ... Research has shown that building shame ... frequency and level of relapse. , At the 2016 iaedp Symposium, ... explore the critical tasks of the recovery phase and beyond including relapse prevention ...
Breaking Medicine News(10 mins):